Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
CR1
Name:
complement C3bC4b receptor 1 (Knops blood group)
Location:
01q32.2
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT00013533 | Pilot Study of Non-Myeloablative HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies | View | |
| NCT00879294 | The Effect of Gum Chewing on Postoperative Ileus | View | |
| NCT06467253 | Comparison of Two Non-invasive Neuromodulation Techniques as Synergistic Therapy to Cognitive Stimulation in Amnestic Mild Cognitive Impairment aMCI | View | |
| NCT04785547 | ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT | View | |
| NCT05339204 | The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission | View | |
| NCT05419596 | The Analysis of Gene Variants Related to POCD in Elderly Patients | View | |
| NCT00096135 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes | View | |
| NCT02450877 | A Study of Safety Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia | View | |
| NCT00153153 | Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients | View | |
| NCT01347996 | Maintenance Therapy With Ceplene Histamine and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia | View | |
| NCT01146977 | Autologous Hematopoietic Cell Transplantation for Core-binding Factor CBF Acute Myeloid Leukemia AML in the First Complete Remission CR1 | View | |
| NCT01234870 | Comprehensive Evaluation of Ischemic Heart Disease Using MRI | View | |
| NCT00957385 | Maintenance Therapy in Acute Myeloid Leukemia AML Patients | View | |
| NCT01565434 | Erythrocyte Complement Receptor 1 and Alzheimer Disease | View | |
| NCT01588951 | Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior | View | |
| NCT02997202 | A Trial of the FMS-like Tyrosine Kinase 3 FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3Internal Tandem Duplication ITD Acute Myeloid Leukemia AML | View | |
| NCT01883362 | Standard of Care - Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML | View | |
| NCT02252107 | 10-day Decitabine Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1 | View | |
| NCT02343562 | Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis | View | |
| NCT04687176 | Frontline Oral Arsenic Trioxide for APL | View | |
| NCT03624270 | Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia | View | |
| NCT05535855 | UCD19 CAR T Therapy in Adults with B-ALL and MRD Positivity in CR1 | View | |
| NCT04489264 | The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma | View | |
| NCT00317642 | A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia AMLCLASSIC I | View | |
| NCT06180863 | Oral Azacitidine CC-486 Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia AML Patients | View | |
| NCT05404906 | AZA Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission | View | |
| NCT02580071 | Chinese Herbal Medicine for Immune Reconstitution Following HSCT in Acute Leukemia Patients | View | |
| NCT02042690 | Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients | View | |
| NCT02059720 | Haplo-SCT vs ASCT With or Without Decitabine in AML CR1 | View | |
| NCT01050036 | Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia | View | |
| NCT02670252 | BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT | View | |
| NCT01520558 | CNDO-109-AANK for AML in First Complete Remission CR1 | View | |
| NCT01513109 | Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia | View | |
| NCT02927262 | A Study of ASP2215 Gilteritinib Administered as Maintenance Therapy Following InductionConsolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 FLT3ITD Acute Myeloid Leukemia AML in First Complete Remission | View | |
| NCT03697707 | Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells DCP-001 in Patients With Acute Myeloid Leukaemia | View |